Monkey Pox Monkeypox Outbreak Just a Few Years After FDA Vaccine Approval
In what can only be called a coincidence, in 2019, the U.S. Food and Drug Administration (FDA) approved the Jynneos Smallpox Monkeypox Vaccine, which is live and non-replicating for the prevention of smallpox and monkeypox disease in adults aged 18 and above determined to be at high risk for these viral infections in what appears